Saturday 17 October 2026
Export MODVQ’s income statement to Excel — free account
ModivCare Inc.
MODVQ Healthcare Medical Care Facilities
ModivCare Inc.’s revenue for fiscal 2024 (year ended December 2024) was $2.8 billion, up 1.32% from fiscal 2023. In the quarter to September 2025, revenue fell 3.18%, EPS fell 171.7% and free cash flow fell 3,767.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
0.02
0.00
0.00%
Follow MODVQ
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
7.45 | 19.48 | 0.00 | 0.00 | 59.75 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
8 | 8 | 7 | 6 | 5 | 2 | 3 | 3 | 3 |
P/S ratio |
0.46 | 0.62 | 0.56 | 0.51 | 1.37 | 1.04 | 0.52 | 0.23 | 0.06 |
Altman Z-Score |
3.54 | 3.89 | 4.98 | 4.95 | 2.66 | 1.96 | 1.90 | 1.43 | 1.28 |
Altman Z″-Score (non-manufacturers) |
3.07 | 2.91 | 3.40 | 3.64 | 1.97 | 0.49 | 0.24 | (0.90) | (1.36) |
P/FCF ratio |
354.39 | 23.31 | 0.00 | 15.31 | 5.59 | 12.59 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.54) | (2.91) | (2.05) | (2.66) | (4.03) | (2.80) | (2.26) | (2.57) | (3.11) |
P/Operating CF |
(161.16) | 45.19 | (53.38) | 36.75 | 30.73 | 171.58 | (23.11) | (24.55) | 5.61 |
P/B ratio |
1.89 | 2.44 | 2.50 | 2.41 | 4.57 | 5.58 | 3.65 | 4.03 | 0.00 |
Price to Tangible BV |
4.37 | 3.61 | 5.20 | 4.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.40 | 0.58 | 0.56 | 0.48 | 1.60 | 1.47 | 0.91 | 0.63 | 0.47 |
EV/EBITDA |
5.03 | 11.88 | 14.71 | 17.22 | 14.69 | 19.69 | 13.95 | 11.29 | 10.23 |
EV/Operating CF |
11.75 | 13.95 | 97.71 | 11.83 | 6.29 | 15.71 | (217.18) | (20.78) | (205.40) |
EV/FCF |
309.15 | 21.86 | (80.22) | 14.39 | 6.52 | 17.74 | (52.20) | (13.77) | (38.67) |
Quick Ratio |
1.10 | 0.75 | 1.12 | 1.63 | 1.22 | 0.70 | 0.63 | 0.73 | 0.75 |
Current Ratio |
1.26 | 1.31 | 1.48 | 1.71 | 1.32 | 0.78 | 0.70 | 0.78 | 0.79 |
Net Debt/EBITDA |
(0.74) | (0.79) | (0.12) | (1.10) | 2.08 | 5.71 | 5.99 | 7.17 | 8.92 |
Debt/Assets |
0.53% | 0.42% | 0.19% | 2.56% | 34.64% | 48.59% | 50.89% | 62.10% | 76.21% |
Debt/Equity |
0.01 | 0.01 | 0.00 | 0.05 | 1.20 | 2.64 | 2.79 | 7.03 | (32.77) |
Asset Turnover |
1.42 | 1.90 | 2.17 | 2.59 | 1.35 | 1.16 | 1.26 | 1.48 | 1.63 |
Operating CF/Net income |
0.54 | 1.29 | (0.31) | (17.73) | 10.73 | (28.37) | 0.33 | 0.41 | 0.03 |
Capex/Depreciation |
(0.81) | (0.73) | (0.62) | (0.63) | (0.45) | (0.36) | (0.31) | (0.14) | (0.12) |
Interest Coverage |
31.79 | 31.13 | 13.62 | 29.10 | 6.93 | 1.82 | 0.92 | (2.02) | (0.99) |
| 26.18% | 13.46% | (7.81%) | (1.09%) | 8.91% | (1.68%) | (8.74%) | (80.06%) | (341.96%) | |
| 8.87% | 6.14% | (3.97%) | (0.59%) | 3.21% | (0.38%) | (1.60%) | (11.02%) | (11.77%) | |
ROIC |
9.92% | 8.22% | 4.98% | 5.70% | 10.56% | 4.56% | 2.68% | (6.99%) | (5.23%) |
Return on Tangible Assets |
72.23% | 39.82% | (27.74%) | (2.65%) | 25.09% | 10.31% | 41.68% | 684.96% | 430.95% |
Average Days of Receivables |
51.70 | 32.11 | 40.22 | 44.43 | 54.28 | 43.48 | 43.26 | 49.77 | 46.72 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
3.20% | 5.30% | 5.57% | 4.45% | 10.35% | 13.60% | 12.86% | 11.07% | 10.70% |
Intangible Assets out of Total Assets |
0.25 | 0.16 | 0.28 | 0.26 | 0.55 | 0.70 | 0.72 | 0.65 | 0.58 |
Share Based Compensation of Revenue |
0.42% | 0.57% | 0.65% | 0.36% | 0.29% | 0.30% | 0.27% | 0.23% | 0.24% |
Graham Net Nets |
(0.04) | (0.09) | (0.06) | (0.03) | (0.32) | (0.60) | (0.96) | (1.92) | (7.10) |
Graham Number |
48.49 | 41.44 | 0.00 | 0.00 | 39.80 | 0.00 | 0.00 | 0.00 | 29.33 |
Earnings Yield |
13.42% | 5.13% | (3.20%) | (0.57%) | 1.67% | (0.33%) | (2.46%) | (32.47%) | (119.51%) |
Free Cash Flow Yield |
0.28% | 4.29% | (1.24%) | 6.53% | 17.88% | 7.94% | (3.36%) | (19.90%) | (20.19%) |
Revenue per Share |
84.12 | 96.91 | 106.86 | 116.52 | 100.88 | 142.09 | 178.10 | 194.10 | 195.76 |
Operating CF per Share |
2.85 | 4.05 | 0.61 | 4.70 | 25.68 | 13.29 | (0.74) | (5.85) | (0.45) |
Capex per Share |
(2.74) | (1.46) | (1.35) | (0.84) | (0.90) | (1.52) | (2.35) | (2.98) | (1.94) |
Free Cash Flow per Share |
0.11 | 2.58 | (0.74) | 3.86 | 24.79 | 11.78 | (3.09) | (8.84) | (2.39) |
Cash per Share |
5.14 | 3.96 | 0.55 | 4.75 | 13.51 | 9.49 | 1.06 | 0.20 | 7.94 |
Shareholders Equity per Share |
25.58 | 24.70 | 23.99 | 24.51 | 30.34 | 26.56 | 25.21 | 11.02 | (2.70) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
25.58 | 24.70 | 23.99 | 24.51 | 30.34 | 26.56 | 25.21 | 11.02 | (2.70) |
Free Cash Flow |
1.59 | 35.12 | (9.62) | 50.08 | 336.29 | 165.52 | (43.45) | (125.26) | (34.04) |
Working Capital |
60.31 | 69.40 | 68.10 | 106.24 | 101.87 | (117.40) | (145.44) | (115.48) | (129.11) |
Capital Expenditures |
(40.18) | (19.92) | (17.52) | (10.86) | (12.15) | (21.32) | (33.00) | (42.29) | (27.63) |
Net Current Asset Value |
(21.94) | (71.74) | (47.67) | (23.36) | (594.77) | (1,244.32) | (1,243.56) | (1,206.16) | (1,197.43) |
EV/EBIT |
10.19 | 20.48 | 31.79 | 29.14 | 17.96 | 32.85 | 39.73 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
Price to Operating Income |
11.69 | 21.84 | 32.04 | 31.01 | 15.41 | 23.32 | 22.66 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.07 | 0.72 | 1.23 | 0.74 | 0.98 | 1.12 | 1.53 | 3.42 | 2.69 |
Cash ROIC |
0.35% | 8.94% | (3.01%) | 12.70% | 30.88% | 11.09% | (3.20%) | (9.97%) | (2.55%) |
Accounts Receivable Turnover |
7.09 | 9.07 | 10.31 | 8.98 | 7.07 | 9.05 | 9.37 | 8.19 | 7.62 |
Accounts Payable Turnover |
45.10 | 106.44 | 274.13 | 150.39 | 118.10 | 184.71 | 63.85 | 41.82 | 34.23 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,354.72 | 0.00 | 0.00 |
Average Days of Payables |
7.15 | 0.10 | 2.57 | 2.55 | 2.86 | 2.00 | 9.87 | 8.75 | 12.81 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
173.99 | 145.36 | 134.28 | 168.21 | 193.67 | 220.70 | 267.35 | 335.98 | 365.98 |
Average Payables |
25.10 | 11.25 | 4.57 | 9.32 | 9.13 | 8.58 | 31.82 | 55.10 | 69.15 |
Average Inventory |
— | — | — | — | — | — | 1.50 | — | — |
Average Assets |
867.74 | 694.68 | 636.87 | 583.51 | 1,011.65 | 1,726.67 | 1,985.85 | 1,855.77 | 1,710.80 |
Average Common Equity |
293.90 | 316.85 | 323.51 | 314.30 | 364.60 | 392.44 | 363.91 | 255.38 | 58.86 |
Columns are period end dates